168 related articles for article (PubMed ID: 15922886)
1. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients.
Kuijt GP; Voogd AC; van de Poll-Franse LV; Scheijmans LJ; van Beek MW; Roumen RM
Eur J Surg Oncol; 2005 Jun; 31(5):500-5. PubMed ID: 15922886
[TBL] [Abstract][Full Text] [Related]
2. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement.
Colleoni M; Rotmensz N; Peruzzotti G; Maisonneuve P; Mazzarol G; Pruneri G; Luini A; Intra M; Veronesi P; Galimberti V; Torrisi R; Cardillo A; Goldhirsch A; Viale G
J Clin Oncol; 2005 Mar; 23(7):1379-89. PubMed ID: 15735114
[TBL] [Abstract][Full Text] [Related]
3. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
4. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis].
Liao YQ; Xu BH
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):615-8. PubMed ID: 18210884
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
Chen SL; Hoehne FM; Giuliano AE
Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
[TBL] [Abstract][Full Text] [Related]
7. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
8. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.
Grabau D; Jensen MB; Rank F; Blichert-Toft M
APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study.
Maaskant-Braat AJ; van de Poll-Franse LV; Voogd AC; Coebergh JW; Roumen RM; Nolthenius-Puylaert MC; Nieuwenhuijzen GA
Breast Cancer Res Treat; 2011 May; 127(1):195-203. PubMed ID: 20680679
[TBL] [Abstract][Full Text] [Related]
11. Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?
de Mascarel I; MacGrogan G; Debled M; Brouste V; Mauriac L
Cancer; 2008 Apr; 112(8):1672-8. PubMed ID: 18286534
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of axillary lymph node micrometastases in breast cancer.
Sakorafas GH; Geraghty J; Pavlakis G
Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients.
Querzoli P; Pedriali M; Rinaldi R; Lombardi AR; Biganzoli E; Boracchi P; Ferretti S; Frasson C; Zanella C; Ghisellini S; Ambrogi F; Antolini L; Piantelli M; Iacobelli S; Marubini E; Alberti S; Nenci I
Clin Cancer Res; 2006 Nov; 12(22):6696-701. PubMed ID: 17121888
[TBL] [Abstract][Full Text] [Related]
14. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer.
Krauth JS; Charitansky H; Isaac S; Bobin JY
Eur J Surg Oncol; 2006 May; 32(4):400-4. PubMed ID: 16504456
[TBL] [Abstract][Full Text] [Related]
16. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
J Clin Oncol; 2010 Jun; 28(17):2868-73. PubMed ID: 20458033
[TBL] [Abstract][Full Text] [Related]
18. The significance of one positive axillary node.
Kuijt GP; van de Poll-Franse LV; Roumen RM; van Beek MW; Voogd AC
Eur J Surg Oncol; 2006 Mar; 32(2):139-42. PubMed ID: 16412602
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of number of positive nodes: a long-term study of one to two nodes versus three nodes in breast cancer patients.
Tai P; Yu E; Joseph K
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):180-7. PubMed ID: 20394852
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
